Join to view full profile
825 Eastlake Ave ESeattle, WA 98109
Phone+1 855-557-0555
Fax+1 206-606-1025
Dr. Scott is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of WashingtonFellowship, Medical Oncology, 1999 - 2000
University of South Alabama College of MedicineClass of 1996
Certifications & Licensure
WA State Medical License 1999 - 2026
MD State Medical License 2000 - 2001
Clinical Trials
Publications & Presentations
PubMed
- 1 citationsiMTSS: An Integrated Framework for Biology- and Patient-Driven Prognosis in Myelofibrosis Undergoing Transplantation.Nico Gagelmann, Rachel B Salit, Thomas Schroeder, Patrizia Chiusolo, Maria Chiara Finazzi
Transplantation and Cellular Therapy. 2026-09-17 - Randomized phase 2 trial of CPX-351 vs. CLAG-M (cladribine, cytarabine, G-CSF, and mitoxantrone) for medically unfit adults with acute myeloid leukemia or other high-g...Anna B Halpern, Megan Othus, Mary-Elizabeth M Percival, Cristina Ghiuzeli, Jacob S Appelbaum
Leukemia. 2026-09-01 - 1 citationsPTCy or ATG for Matched Transplantation in Myelofibrosis.Patrizia Chiusolo, Andrea Bacigalupo, Rachel Salit, Thomas Schroeder, Maria Chiara Finazzi
American Journal of Hematology. 2026-06-01
Journal Articles
- Phase 1/2 Trial of Cladribine, High-Dose Cytarabine, Mitoxantrone, and G-CSF with Dose-Escalated Mitoxantrone for relapsed/refractory Acute Myeloid Leukemia or Other H...Kelda M Gardner, Vivian G Oehler, Heather A Smith, Anna B Halpern, Paul C Hendrie, Sarah A Buckley, Roland B Walter, Pamela S Becker, Ryan D Cassaday, Asma Anwar, Bart..., Haematologica
- Recipient Single Nucleotide Polymorphisms in Paneth Cell Antimicrobial Peptide Genes and Acute Graft‐Versus‐Host Disease: Analysis of BMT CTN‐0201 and ‐0901 SamplesArmin Rashidi, Edmund K Waller, Bharat Thyagarajan, Claudio Anasetti, Daniel J Weisdorf, Bart L Scott, Bruce R Blazar, British Journal of Haematology
Abstracts/Posters
- Comparison of Outcomes after Early Hospital Discharge (EHD) Following Intensive Induction Vs. Post-Remission Chemotherapy for Adults with Acute Myeloid Leukemia (AML) ...Bart L. Scott, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- The Oral JAK2/IRAK1 Inhibitor Pacritinib Demonstrates Spleen Volume Reduction in Myelofibrosis Patients Independent of JAK2V617F Allele BurdenBart L. Scott, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Diagnostic Testing Patterns and Concordance with World Health Organization (WHO) Criteria for Patients (Pts) with Newly Diagnosed (ND) Myelodysplastic Syndromes (MDS) ...Bart L. Scott, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Lectures
- A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Stem Cell Transplant in Patients with Myelodysplastic Syndromes: On Behalf of the CIBMTR Ch...2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Successes in Bone Marrow Failures - 2011 ASH SatelliteCleveland Clinic - Cleveland, Ohio / The Cleveland Clinic Foundation, San Diego, California - 12/9/2011
Press Mentions
For Patients with Rare Blood Cancer, New Drug Offers ReliefJune 16th, 2025- Fred Hutch at ASCO: New Insights on Financial Toxicity, Combination Therapies for Cancer and the Need for Targeted Breast Cancer Therapies in UgandaMay 26th, 2023
- Column: We Pray for Damar Hamlin — and Then Settle Back in for More FootballJanuary 8th, 2023
Grant Support
- Improving Allogenic Transplant Outcomes In Myeloid MalignanciesNational Heart, Lung, And Blood Institute2007–2011
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: